PharmaCyte Biotech Inc (PMCB)

Name: PharmaCyte Biotech Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-10-31

Latest Quarter

2025-10-31

Revenue

$0.0

Net Income

-$8.4M

Operating Margin

N/A

Free Cash Flow

-$3.0M

Debt / Assets

5.9%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for PharmaCyte Biotech Inc (PMCB).
Income Statement (Quarterly)	2025-10-31	2025-07-31	2025-01-31	2024-10-31
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,234,966	753,148	609,193	117,572
Operating Expenses	1,376,051	848,305	960,252	1,106,060
Operating Income	-1,376,051	-848,305	-960,252	-1,106,060
Interest Expense	0	0	0	0
Income Before Tax	-8,416,610	-8,360,096	-3,045,328	-1,469,560
Income Tax Expense	0	0	0	0
Net Income	-8,416,610	-8,360,096	-3,045,328	-1,469,560
Per Share
EPS	-1.24	-1.23	-0.44	-0.39
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for PharmaCyte Biotech Inc (PMCB).
Income Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Revenue	0	0	0	0	0
Cost of Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	3,939,446	2,117,000	4,752,000	3,701,077	2,706,732
Operating Expenses	4,377,862	6,520,000	6,455,000	4,392,014	3,622,981
Operating Income	-4,377,862	-8,520,000	-6,455,000	-4,392,014	-3,622,981
Interest Expense	0	0	0	509	3,046
Income Before Tax	30,656,050	333,763	-4,316,000	-4,239,161	-3,551,236
Income Tax Expense	0	0	-1,937,000	-153,362	0
Net Income	30,656,050	333,763	-4,316,000	-4,085,799	-3,551,236
Per Share
EPS	3.19	-1.80	-0.22	-0.26	-2.45
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for PharmaCyte Biotech Inc (PMCB).
Balance Sheet (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Assets
Cash and Cash Equivalents	15,172,163	50,179,968	68,039,936	85,400,656
Short Term Investments	366,316	0	0	0
Net Receivables	3,696,000	0	0	0
Inventory	0	0	0	0
Total Current Assets	22,375,238	50,439,768	68,147,617	85,494,828
Property Plant Equipment	0	0	0	0
Goodwill and Intangibles	1,549,427	1,549,427	3,549,427	3,549,427
Total Assets	55,168,353	59,903,883	73,276,925	90,624,136
Liabilities
Account Payables	399,204	389,369	128,281	205,361
Short Term Debt	0	0	0	0
Total Current Liabilities	2,914,284	7,421,264	586,581	704,370
Long Term Debt	0	0	0	0
Total Liabilities	3,277,284	20,389,264	586,581	704,370
Shareholders Equity
Retained Earnings	-84,968,960	-115,625,010	-115,958,773	-111,648,656
Total Shareholders Equity	51,891,069	39,514,619	72,690,344	89,919,766

Balance sheet annual history for PharmaCyte Biotech Inc (PMCB).
Balance Sheet (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Assets
Cash and Cash Equivalents	15,172,163	50,179,968	68,039,936	85,400,656	2,202,106
Short Term Investments	366,316	0	0	0	0
Net Receivables	3,696,000	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	22,375,238	50,439,768	68,147,617	85,494,828	2,275,237
Property Plant Equipment	0	0	0	0	0
Goodwill and Intangibles	1,549,427	1,549,427	3,549,427	3,549,427	3,549,427
Total Assets	55,168,353	59,903,883	73,276,925	90,624,136	7,404,229
Liabilities
Account Payables	399,204	389,369	128,281	205,361	172,261
Short Term Debt	0	0	0	0	0
Total Current Liabilities	2,914,284	7,421,264	586,581	704,370	724,778
Long Term Debt	0	0	0	0	0
Total Liabilities	3,277,284	20,389,264	586,581	704,370	724,778
Shareholders Equity
Retained Earnings	-84,968,960	-115,625,010	-115,958,773	-111,648,656	-107,409,495
Total Shareholders Equity	51,891,069	39,514,619	72,690,344	89,919,766	6,679,451

Cash flow quarterly history for PharmaCyte Biotech Inc (PMCB).
Cash Flow Statement (Quarterly)	2025-04-30	2024-04-30	2023-04-30	2022-04-30
Operating Activities
Net Income	30,656,050	333,763	-4,315,993	-4,239,161
Depreciation & Amortization	0	0	0	0
Stock Based Compensation	478,637	675	645,406	77,956
Change in Working Capital	1,356,333	298,894	-297,166	9,040
Operating Cash Flow	-2,978,296	-2,151,457	-3,793,731	-4,117,319
Investing Activities
Capital Expenditure	-4	0	0	0
Investments	0	0	0	0
Investing Cash Flow	-7,000,000	-5,000,000	0	0
Financing Activities
Debt Repayment	0	0	0	-50,805
Common Stock Issued/Repurchased	-25,029,151	-10,708,003	-13,559,743	87,362,049
Dividends Paid	-1,129,759	0	0	0
Financing Cash Flow	-25,029,151	-10,708,003	-13,559,743	87,311,244
Summary
Free Cash Flow	-2,978,296	-2,151,457	-3,793,731	-4,117,319
Net Change in Cash	-35,007,805	-17,859,968	-17,360,720	83,198,550

Cash flow annual history for PharmaCyte Biotech Inc (PMCB).
Cash Flow Statement (Annual)	2025-04-30	2024-04-30	2023-04-30	2022-04-30	2021-04-30
Operating Activities
Net Income	30,656,050	333,763	-4,315,993	-4,239,161	-3,551,236
Depreciation & Amortization	0	0	0	0	0
Stock Based Compensation	478,637	675	645,406	77,956	370,829
Change in Working Capital	1,356,333	298,894	-297,166	9,040	-145,608
Operating Cash Flow	-2,978,296	-2,151,457	-3,793,731	-4,117,319	-3,330,889
Investing Activities
Capital Expenditure	-4	0	0	0	0
Investments	0	0	0	0	0
Investing Cash Flow	-7,000,000	-5,000,000	0	0	0
Financing Activities
Debt Repayment	0	0	0	-50,805	-62,440
Common Stock Issued/Repurchased	-25,029,151	-10,708,003	-13,559,743	87,362,049	4,699,247
Dividends Paid	-1,129,759	0	0	0	0
Financing Cash Flow	-25,029,151	-10,708,003	-13,559,743	87,311,244	4,636,807
Summary
Free Cash Flow	-2,978,296	-2,151,457	-3,793,731	-4,117,319	-3,330,889
Net Change in Cash	-35,007,805	-17,859,968	-17,360,720	83,198,550	1,307,245